Critical Reviews in Clinical Laboratory Sciences

Papers
(The TQCC of Critical Reviews in Clinical Laboratory Sciences is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
The COVID-19 pandemic738
Biomarkers associated with COVID-19 disease progression528
COVID-19: from an acute to chronic disease? Potential long-term health consequences216
Current concepts and advances in biomarkers of acute kidney injury78
The COVID-19 pandemic: viral variants and vaccine efficacy65
Effects of age, sex, serostatus, and underlying comorbidities on humoral response post-SARS-CoV-2 Pfizer-BioNTech mRNA vaccination: a systematic review56
Vitamin B12status in health and disease: a critical review. Diagnosis of deficiency and insufficiency – clinical and laboratory pitfalls53
Potential value and impact of data mining and machine learning in clinical diagnostics52
A summary of the diagnostic and prognostic value of hemocytometry markers in COVID-19 patients51
Preanalytical variables that affect the outcome of cell-free DNA measurements49
Vitamin D: sources, physiological role, biokinetics, deficiency, therapeutic use, toxicity, and overview of analytical methods for detection of vitamin D and its metabolites49
Molecular diagnostic assays for COVID-19: an overview46
The laboratory’s role in combating COVID-1936
Recent evolutions of machine learning applications in clinical laboratory medicine25
The role of soluble receptor for advanced glycation end-products (sRAGE) in the general population and patients with diabetes mellitus with a focus on renal function and overall outcome22
The molecular structure and biological functions of RNA methylation, with special emphasis on the roles of RNA methylation in autoimmune diseases22
Breathing new life into clinical testing and diagnostics: perspectives on volatile biomarkers from breath21
Molecular tissue profiling by MALDI imaging: recent progress and applications in cancer research21
Implementation of patient-based real-time quality control21
Procalcitonin for individualizing antibiotic treatment: an update with a focus on COVID-1920
Liquid biopsy with cell free DNA: new horizons for prostate cancer19
Nucleic acid-based electrochemical biosensors for rapid clinical diagnosis: advances, challenges, and opportunities19
What the lab can and cannot do: clinical interpretation of drug testing results19
T helper cells in depression: central role of Th17 cells18
The potential impact of salivary peptides in periodontitis18
The role of kallikreins in inflammatory skin disorders and their potential as therapeutic targets16
Clinical applications of extracellular vesicle long RNAs16
Oligoclonal bands: clinical utility and interpretation cues15
CRISPR-based biosensing systems: a way to rapidly diagnose COVID-1915
Choice of SARS-CoV-2 diagnostic test: challenges and key considerations for the future15
Immunologic evaluation and genetic defects of apoptosis in patients with autoimmune lymphoproliferative syndrome (ALPS)15
Multiple biomarker approach for the diagnosis and therapy of rheumatoid arthritis14
Quantifying RNA modifications by mass spectrometry: a novel source of biomarkers in oncology13
Identifying and overcoming barriers to harmonize newborn screening programs through consensus strategies13
Smartphone technology facilitates point-of-care nucleic acid diagnosis: a beginner’s guide13
Systematic review and meta-analysis of C-reactive protein as a biomarker in breast cancer13
DropWise: current role and future perspectives of dried blood spots (DBS), blood microsampling, and their analysis in sports drug testing13
0.016103029251099